MedPath

GABAPENTIN

These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral useInitial U.S. Approval: 1993

Approved
Approval ID

11580370-55dd-4b61-b051-68b49f6fd2ea

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 5, 2021

Manufacturers
FDA

Ascent Pharmaceuticals, Inc

DUNS: 080938961

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Gabapentin

PRODUCT DETAILS

NDC Product Code43602-467
Application NumberANDA214957
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateOctober 5, 2021
Generic NameGabapentin

INGREDIENTS (8)

GABAPENTINActive
Quantity: 800 mg in 1 1
Code: 6CW7F3G59X
Classification: ACTIB
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 9XZ8H6N6OH
Classification: IACT
CROSPOVIDONEInactive
Code: 2S7830E561
Classification: IACT
GLYCERYL DIBEHENATEInactive
Code: R8WTH25YS2
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

Gabapentin

PRODUCT DETAILS

NDC Product Code43602-466
Application NumberANDA214957
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateOctober 5, 2021
Generic NameGabapentin

INGREDIENTS (8)

MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
GABAPENTINActive
Quantity: 600 mg in 1 1
Code: 6CW7F3G59X
Classification: ACTIB
HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 9XZ8H6N6OH
Classification: IACT
CROSPOVIDONEInactive
Code: 2S7830E561
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
GLYCERYL DIBEHENATEInactive
Code: R8WTH25YS2
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GABAPENTIN - FDA Drug Approval Details